• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向人类 SIRT5 活性位点的化学探测揭示了其底物酰基特异性和基于肽的抑制剂。

Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors.

机构信息

Department of Enzymology, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strasse 3, 06120 Halle/Saale (Germany).

出版信息

Angew Chem Int Ed Engl. 2014 Sep 26;53(40):10728-32. doi: 10.1002/anie.201402679. Epub 2014 Aug 11.

DOI:10.1002/anie.201402679
PMID:25111069
Abstract

Sirtuins are NAD(+)-dependent deacetylases acting as sensors in metabolic pathways and stress response. In mammals there are seven isoforms. The mitochondrial sirtuin 5 is a weak deacetylase but a very efficient demalonylase and desuccinylase; however, its substrate acyl specificity has not been systematically analyzed. Herein, we investigated a carbamoyl phosphate synthetase 1 derived peptide substrate and modified the lysine side chain systematically to determine the acyl specificity of Sirt5. From that point we designed six potent peptide-based inhibitors that interact with the NAD(+) binding pocket. To characterize the interaction details causing the different substrate and inhibition properties we report several X-ray crystal structures of Sirt5 complexed with these peptides. Our results reveal the Sirt5 acyl selectivity and its molecular basis and enable the design of inhibitors for Sirt5.

摘要

沉默调节蛋白是 NAD(+)依赖的去乙酰化酶,作为代谢途径和应激反应的传感器。在哺乳动物中有七种同工酶。线粒体沉默调节蛋白 5 是一种弱去乙酰化酶,但却是一种非常有效的脱酰基酶和脱琥珀酰酶;然而,其底物酰基特异性尚未得到系统分析。在此,我们研究了一种由氨基甲酰磷酸合成酶 1 衍生的肽底物,并系统修饰赖氨酸侧链,以确定 Sirt5 的酰基特异性。从这一点出发,我们设计了六个有效的基于肽的抑制剂,与 NAD(+)结合口袋相互作用。为了阐明导致不同底物和抑制特性的相互作用细节,我们报告了 Sirt5 与这些肽结合的几个 X 射线晶体结构。我们的结果揭示了 Sirt5 的酰基选择性及其分子基础,并为 Sirt5 的抑制剂设计提供了依据。

相似文献

1
Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors.靶向人类 SIRT5 活性位点的化学探测揭示了其底物酰基特异性和基于肽的抑制剂。
Angew Chem Int Ed Engl. 2014 Sep 26;53(40):10728-32. doi: 10.1002/anie.201402679. Epub 2014 Aug 11.
2
Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.苏拉明对人NAD⁺依赖性脱乙酰酶SIRT5的抑制作用的结构基础
Structure. 2007 Mar;15(3):377-89. doi: 10.1016/j.str.2007.02.002.
3
Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors.Sirtuin 5:结构综述、已知抑制剂及开发新型抑制剂的线索。
Sci China Life Sci. 2017 Mar;60(3):249-256. doi: 10.1007/s11427-016-0060-7. Epub 2016 Nov 17.
4
Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.哺乳动物中线粒体去乙酰化酶亚型Sirt5的功能与调控
Biochim Biophys Acta. 2010 Aug;1804(8):1658-65. doi: 10.1016/j.bbapap.2009.09.011. Epub 2009 Sep 18.
5
The ɛ-Amino Group of Protein Lysine Residues Is Highly Susceptible to Nonenzymatic Acylation by Several Physiological Acyl-CoA Thioesters.蛋白质赖氨酸残基的ε-氨基极易被几种生理性酰基辅酶A硫酯进行非酶酰化。
Chembiochem. 2015 Nov 2;16(16):2337-47. doi: 10.1002/cbic.201500364. Epub 2015 Sep 18.
6
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.Sirt5 是一种 NAD 依赖性蛋白赖氨酸脱琥珀酰酶和去琥珀酰酶。
Science. 2011 Nov 11;334(6057):806-9. doi: 10.1126/science.1207861.
7
The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).双环中间体结构为深入了解人源 SIRT5(去琥珀酰化酶 5)的去琥珀酰化机制提供了线索。
J Biol Chem. 2012 Aug 17;287(34):28307-14. doi: 10.1074/jbc.M112.384511. Epub 2012 Jul 5.
8
Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.Sirt5 的去酰化酶活性对烟酰胺的抑制作用表现出不同的敏感性。
PLoS One. 2012;7(9):e45098. doi: 10.1371/journal.pone.0045098. Epub 2012 Sep 19.
9
Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation features.线粒体去酰化酶 Sirtuin 4 的晶体结构揭示了同工型特异性酰基识别和调节特征。
Nat Commun. 2017 Nov 15;8(1):1513. doi: 10.1038/s41467-017-01701-2.
10
Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5.人类线粒体去乙酰化酶Sirt3和Sirt5的底物及调控机制。
J Mol Biol. 2008 Oct 10;382(3):790-801. doi: 10.1016/j.jmb.2008.07.048. Epub 2008 Jul 25.

引用本文的文献

1
Unraveling Small Molecule-Mediated Sirtuin 3 Activation at a Distinct Binding Site for Cardioprotective Therapies.解析小分子在独特结合位点介导的Sirtuin 3激活以用于心脏保护治疗
ACS Cent Sci. 2025 Apr 14;11(5):704-718. doi: 10.1021/acscentsci.5c00023. eCollection 2025 May 28.
2
SIRT5: a potential target for discovering bioactive natural products.沉默调节蛋白5:发现生物活性天然产物的潜在靶点。
J Nat Med. 2025 May;79(3):441-464. doi: 10.1007/s11418-024-01871-6. Epub 2025 Feb 20.
3
The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases.
III 类组蛋白去乙酰化酶(Sirtuins)的结构、功能和在神经精神疾病中的作用。
Cells. 2024 Oct 2;13(19):1644. doi: 10.3390/cells13191644.
4
Sirtuin insights: bridging the gap between cellular processes and therapeutic applications.Sirtuin 研究进展:连接细胞过程与治疗应用之间的桥梁。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9315-9344. doi: 10.1007/s00210-024-03263-9. Epub 2024 Jul 8.
5
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies.线粒体 Sirtuins 在癌症中的作用:从分子机制到治疗策略的再评价
Theranostics. 2024 May 11;14(7):2993-3013. doi: 10.7150/thno.97320. eCollection 2024.
6
SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process.SIRT3 激活——药物研发的新希望?深入探讨 SIRT3 生物学及其对药物发现过程的影响
J Med Chem. 2024 Feb 8;67(3):1662-1689. doi: 10.1021/acs.jmedchem.3c01979. Epub 2024 Jan 23.
7
Succinylation modification: a potential therapeutic target in stroke.琥珀酰化修饰:中风的潜在治疗靶点
Neural Regen Res. 2024 Apr;19(4):781-787. doi: 10.4103/1673-5374.382229.
8
The Role of Sirtuin 1 (SIRT1) in Neurodegeneration.沉默调节蛋白1(SIRT1)在神经退行性变中的作用
Cureus. 2023 Jun 15;15(6):e40463. doi: 10.7759/cureus.40463. eCollection 2023 Jun.
9
Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5.强效且特异的线粒体 Sirtuins Sirt3 和 Sirt5 的激活剂。
J Med Chem. 2022 Oct 27;65(20):14015-14031. doi: 10.1021/acs.jmedchem.2c01215. Epub 2022 Oct 13.
10
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase.基于芳基氟硫酸酯的抑制剂,共价靶向 SIRT5 赖氨酸脱酰酶。
Angew Chem Int Ed Engl. 2022 Nov 21;61(47):e202204565. doi: 10.1002/anie.202204565. Epub 2022 Oct 21.